Zydus Lifesciences obtained final clearance from the USFDA for Darunavir Tablets, an antiviral medication used in treating HIV-1 infection....

Darunavir tablets, 600 mg and 800 mg, in combination with other antiretroviral agents, are indicated for the treatment of HIV-1 infection i...

Promoters held 47.07 per cent stake in the company as of 30-Jun-2023, while FIIs owned 13.93 per cent, DIIs 28.94 per cent.

Lupin's shares reached a 52-week high of INR 830.3 after it announced the launch of its Darunavir Tablets to market a generic equivalent of...

Drug firm Lupin on Tuesday said it has received an approval from the US health regulator to market Darunavir Tablets, used to treat Human I...

Favipiravir, an off-patent drug originally owned by Japanese drug maker Fuji, holds potential against RNA viruses, one of which is Covid-19...

Over 170,000 individuals across the world have been infected by the novel coronavirus and 6,509 have died, with cases and deaths outside Ch...

The FDC drug ‘Darunavir+Ritonavir’ is an anti-retroviral medication indicated for the treatment of human immunodeficiency virus (HIV-1) in ...

Lupin moved higher in trade as the Mumbai-based drug maker got a tentative approval from the USFDA to market Darunavir Ethanolate tablets.

Drug firm Lupin has received tentative approval from the US health regulator to market a generic version of Prezista tablets, used in treat...

Doctors Without Borders warned today that rising intellectual property rights are blocking the generic production of newer drugs to treat H...

An independent mechanism that protects the patent rights of Big Pharma while allowing generic firms to sell cheap, copycat HIV drugs to poo...

Patient advocacy and civil society groups working in the area of HIV/AIDS have criticized free trade agreements (FTAs) being signed between...